Experience Matters

Providing expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia.

Welcome to Lucid Health Consulting: Your Gateway to Pharmaceutical and Medical Markets in Australia and the Asia-Pacific

With over 30 years of industry leadership, Lucid Health Consulting is the trusted partner for companies and associations in the pharmaceuticals, medical device, medical technology, and biotech sectors in Australia.

Our team of experts includes health economists, regulatory affairs specialists, reimbursement and HTA consultants, market and patient access advisors, and statisticians. We have a proven track record of enabling companies and organisations to optimise the entry of their pharmaceuticals, biotech products medical devices and technologies into the Australian market.

Whether you’re looking to overcome complex regulatory hurdles, answer critical business questions, streamline your market entry process or require product sponsorship in Australia, we are here to help.

Let us help you unlock new opportunities and drive success across Australia and the Asia-Pacific region.

How we can help your business?

Product Sponsorship and Commercialisation

Regulatory Affairs, Compliance and Advocacy

Reimbursement Submissions (PBAC, MSAC, LSDP, PL)

Market Access and Pricing Strategy

Statistical Analyses, Research, and Market Intelligence

Economic Modelling and Evaluations

Unlock the potential of the Asia-Pacific Market with Lucid Health Consulting

Asia Pacific partnership

Let us help facilitate your pathway to successful approval and launch of your pharmaceuticals, biotech products, medical devices, and technologies across the Asia-Pacific Region through our strategic partnership with Vista Health , headquartered in Singapore, with offices in Japan and the UK.

Together, we leverage our combined expertise and expansive network across the region to offer tailored advice, strategic insights, and seamless implementation, paving the way for your successful market entry across the Asia-Pacific region.

What’s New

Read our articles, find out about our upcoming webinars and speaking engagements for the latest industry insights.

Lucid Health Consulting: NEWSLETTER #1 – February 2024.

Lucid Health Consulting: NEWSLETTER #1 – February 2024.

Read our first newsletter of 2024, "2024 - The Australian Healthcare Market Outlook" as we share our key projections for 2024, recap highlights from 2023, spotlight upcoming Australian and Global Industry events we’ll be attending, and unveil useful online resources,...

read more
ISPOR Europe 2023, 12-15 November, with our Poster.

ISPOR Europe 2023, 12-15 November, with our Poster.

The ISPOR Europe 2023 conference for 2023 was held this year in Copenhagen, Denmark on 12 – 15 November, with the theme:  "HEOR at the Nexus of Policy and Science"   The road to policy and clinical integration for health technologies is filled with diverse and...

read more
9th Annual Drugs & Devices Australia Webinar – 2023

9th Annual Drugs & Devices Australia Webinar – 2023

9th Annual Drugs & Devices Australia Webinar - 2023 When: 30 November, 8:30am AEST and 29 November 2023, 1:30pm PST. Please join our Director, George Papadopoulos and Sarah Griffin, Director of MedTechnique Consulting for their annual Drugs & Devices...

read more

What our clients are saying.

The Lucid Health Consulting team did a fantastic job with our funding application. The indication was complex, with multiple sub-populations and a varied treatment pathway. But they put together a clear and well-reasoned clinical evaluation, and translated this into a compelling economic assessment. Their broad experience and expertise meant they could provide valuable strategic insights throughout the submission process, ultimately leading to a positive recommendation the first time of asking – no mean feat. I would highly recommend their services.

Market Access Manager, Takeda.

The Lucid team’s thoughtful consideration of the strategic direction of a submission, their expert economic modelling skills and their ability to draw out the narrative of the value proposition ensures that the overall cost-effectiveness outcome is compelling to technical evaluators and general payers alike.

Head of Patient Services & Government Affairs ANZ, Baxalta

Lucid Heath Consulting are excellent to work with. All of their work is both scientifically rigorous and clearly articulated. Our very complex case was presented to us in a compelling way. The Directors at Lucid Health Consulting, have a great hands on approach and good direct dialogue with the relevant people in our organisation. We enjoyed working with Lucid Health Consulting and would recommend them and use them ourselves for our future projects.

Executive Director Integrated Market Access, Janssen-Cilag

Lucid Health Consulting are proud members of

Lucid Health Consulting are providers of expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.

ADDRESS

32 Mitchell St, McMahon's Pt NSW 2060

GET IN TOUCH

7 + 10 =